Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Hairy Cell Leukemia with Marrow Reactive Plasmacytosis and Mast Cell Hyperplasia: A Case Report and Brief Review of the Literature

Document Type : Case Report

Authors

1 Pathology and Stem Cells Research Center, Pathology Department, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Department of Internal Medicine, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

3 School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Hairy cell leukemia (HCL) and HCL-like disorders, including HCL-variant, are disorders of heterogeneous mature lymphoid B-cells known for their hairy cell infiltration accompanied by a specific genetic profile, various clinical presentations, and, as they are uncommon hematological malignancies characterized by pancytopenia, the need for appropriate therapy. Sometimes HCL creates diagnostic challenges for clinicians, and its coincidence or association with mast cell and plasma cell infiltration is a rare condition. Herein, we report a case of HCL with confusing manifestations. A 44-year-old man was referred to the hospital for weakness, fatigue, and watery, non-bloody diarrhea. The laboratory tests showed pancytopenia, leading to a referral for bone marrow aspiration and biopsy. Medium to large cells exhibiting widespread cytoplasm, oval nuclei similar to monocyte nuclei (kidney-shaped) accompanied by an increased number of mast cells, and plasma cells were observed in the biopsy sample. In flow cytometry, the neoplastic cells were positive for CD19, FMC7, and the co-expression of the CD20/CD25, CD11C/CD22, and CD103 markers. In immunohistochemical staining, the mast cells were positive for CD117, the plasma cells were positive for CD138, and the hairy cells were positive for CD20. Overall, hematopathologists must be aware of various morphologic confounding factors such as lack of typical cell morphological features and increased plasma cell and mast cell infiltration in the diagnosis of patients with HCL.
 

Highlights

Elham Jafari(Google scholar)(Pubmed)

Behjat Kalantari Khandani(Google scholar)(Pubmed)

Melika Baghershahi(Google scholar)(Pubmed)

Keywords

References

  1. Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V,

    Barrientos J, Blachly JS, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017;129(5):553-60. doi: 10.1182/ blood-2016-01-689422 .

  2. Divino V, Karve S, Gaughan A, DeKoven M, Gao G, Knopf KB, et al. Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. J Comp Eff Res. 2017;6(6):497-508. doi: 10.2217/ cer-2017-0014.

  3. Andritsos LA, Grever MR. Historical overview of hairy cell leukemia. Best Pract Res Clin Haematol. 2015;28(4):166-74. doi: 10.1016/j.beha.2015.10.018.

  4. Tiacci E, Pettirossi V, Schiavoni G, Falini B. Genomics of hairy cell leukemia. J Clin Oncol. 2017;35(9):1002-10. doi: 10.1200/jco.2016.71.1556.

  5. Durham BH, Getta B, Dietrich S, Taylor J, Won H, Bogenberger JM, et al. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood. 2017;130(14):1644-8. doi: 10.1182/blood-2017-01-765107.

  6. Pettirossi V, Santi A, Imperi E, Russo G, Pucciarini A, Bigerna B, et al. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity. Blood. 2015;125(8):1207-16. doi: 10.1182/blood-2014-10-603100.

  7. Alfaraj M, Alsaeed H. Hairy cell leukemia: a case report of atypical presentation without splenomegaly. Blood Res. 2017;52(2):139-41. doi: 10.5045/br.2017.52.2.139.

  8. Parry-Jones N, Joshi A, Forconi F, Dearden C; BSH guidelines committee. Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V). Br J Haematol. 2020 ;191(5):730-7. doi: 10.1111/bjh.17055.

  9. Saif MW, Greenberg BR. Multiple myeloma and hairy cell leukemia: a rare association or coincidence? Leuk Lymphoma. 2001;42(5):1043-8. doi: 10.3109/10428190109097724.

  10. Hanbali A, Alrajeh A, Rasheed W. Plasma cell leukemia mimicking hairy cell leukemia. Hematol Oncol Stem Cell Ther. 2015;8(2):91-2. doi: 10.1016/j.hemonc.2015.05.001.

  11. Streu E. Hairy cell leukemia and bone pain. Oncol Nurs Forum. 2016;43(1):18-21. doi: 10.1188/16.onf.18-21.

  12. Tadmor T, Polliack A. Epidemiology and environmental risk in hairy cell leukemia. Best Pract Res Clin Haematol. 2015;28(4):175-9. doi: 10.1016/j.beha.2015.10.014.

  13. Hoffman MA. Clinical presentations and complications of hairy cell leukemia. Hematol Oncol Clin North Am. 2006;20(5):1065-73. doi: 10.1016/j.hoc.2006.06.003.

  14. Platanias LC, Golomb HM. Hairy cell leukaemia. Baillieres Clin Haematol. 1993;6(4):887-98. doi: 10.1016/s0950-

3536(05)80182-9.
15. Varma N, Marwaha N, Varma S, Sarode R, Garewal G, Dash

S. A clinico-pathological study of six cases of hairy cell

leukaemia. Indian J Pathol Microbiol. 1991;34(1):7-12.
16. Andritsos LA, Grever MR. Historical overview of hairy cell leukemia. Best Pract Res Clin Haematol. 2015;28(4):166-74.

doi: 10.1016/j.beha.2015.10.018.
17. Quest GR, Johnston JB. Clinical features and diagnosis of hairy

cell leukemia. Best Pract Res Clin Haematol. 2015;28(4):180-

92. doi: 10.1016/j.beha.2015.10.017.
18. Getta BM, Park JH, Tallman MS. Hairy cell leukemia:

past, present and future. Best Pract Res Clin Haematol.

2015;28(4):269-72. doi: 10.1016/j.beha.2015.10.015.
19. Rastogi P, Sreedharanunni S, Yanamandra U, Sachdeva MUS, Varma N. Morphologic confounders and CD19 negativity in a case of hairy cell leukemia. Mediterr J Hematol Infect Dis.

2017;9(1):e2017033. doi: 10.4084/mjhid.2017.033.
20. Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM. Hairy cell leukemia: a tumor of pre-plasma cells.

Blood. 1985;65(3):620-9.
21. Sharma A, Buxi G, Marwah S, Yadav RB. Hairy cell

leukemia: an unusual morphology. Indian J Pathol Microbiol.

2010;53(4):891-3. doi: 10.4103/0377-4929.72045.
22. Korde N, Mailankody S, Arons E, Braylan RC, Raffeld M, Maestri E, et al. Series of hairy cell leukemia patients with co-existent plasma cell disorders. Blood. 2014;124(21):5647.

doi: 10.1182/blood.V124.21.5647.5647.
23. Gupta K, Jasmina A, Malhotra P, Varma N, Vaiphei K, Vohra

H, et al. Hairy cell leukemia-variant--a case report. Indian J

Pathol Microbiol. 2005;48(3):387-9.
24. Franssila KO. Hairy cell leukaemia. A clinico-pathologic

study of 16 patients. Ann Clin Res. 1983;15(2):71-9.
25. Bernadou A, Pelletier G, Cadiou M, Giannoni F, James JM, Bilski-Pasquier G. [Hairy cell leukemia. I.--Clinical, biological and evolutive study on twenty-eight cases (author’s transl)].

Sem Hop. 1981;57(33-36):1361-5. [French].
26. Jian C, Hsia CC. A unique hairy cell leukemia variant. Case

Rep Oncol. 2016;9(2):312-6. doi: 10.1159/000446696.
27. Galani KS, Subramanian PG, Gadage VS, Rahman K, Ashok Kumar MS, Shinde S, et al. Clinico-pathological profile of hairy cell leukemia: critical insights gained at a tertiary care cancer hospital. Indian J Pathol Microbiol. 2012;55(1):61-5.

doi: 10.4103/0377-4929.94858.
28. Gupta AK, Sachdeva MU, Ahluwalia J, Das R, Naseem S,

Sharma P, et al. Haematological profile of 21 patients with hairy cell leukaemia in a tertiary care centre of north India. Indian J Med Res. 2015;142(4):426-9. doi: 10.4103/0971- 5916.169204.

29. Karoopongse E, Khuhapinant A, Auewarakul CU. A rare occurrence of hairy cell leukemia in the Thai population: a case report. J Med Assoc Thai. 2010;93 Suppl 1:S196-202.

30. Rajeswari G, Paul TR, Uppin MS, Uppin SG, Rao DR, Raju DD, et al. Plasma cell leukemia: a case series from South India with emphasis on rarer variants. Indian J Med Paediatr Oncol. 2014;35(3):211-4. doi: 10.4103/0971-5851.142037.

31. Gangadhar P, Ahmed Z, Pai MR, Sandhya I. Primary plasma cell leukemia: a report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature. Indian J Pathol Microbiol. 2016;59(4):541-4. doi: 10.4103/0377-4929.191818.

32. Albarracin F, Fonseca R. Plasma cell leukemia. Blood Rev. 2011;25(3):107-12. doi: 10.1016/j.blre.2011.01.005.

33. Basso K, Liso A, Tiacci E, Benedetti R, Pulsoni A, Foa R,

Hairy cell leukemia with reactive plasmacytosis et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199(1):59-68. doi: 10.1084/jem.20031175.

  1. Tanioka F, Tamashima S, Shimizu S, Kobayashi H, Kobayashi Y, Sugimura H. A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein. Immunohistochemical and molecular analysis. Jpn J Clin Oncol. 2003;33(5):232-7. doi: 10.1093/jjco/hyg043.

  2. Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia: report of a case and review of the literature.

Mayo Clin Proc. 1986;61(12):957-66. doi: 10.1016/s0025-

6196(12)62636-6.
36. Bain BJ. Systemic mastocytosis and other mast cell neoplasms.

Br J Haematol. 1999;106(1):9-17. doi: 10.1111/j.1365-

2141.1999.01458.x.
37. Clancy RL, Gauldie J, Vallieres M, Bienenstock J, Day RP,

Pineo GF. An approach to immunotherapy using antibody to IgE in mast cell leukemia. Cancer. 1976;37(2):693- 6. doi: 10.1002/1097-0142(197602)37:2<693::aid- cncr2820370213 > 3.0.co;2-x.

Journal of Kerman University of Medical Sciences
Volume 30, Issue 3
May and June 2023
Pages 184-188
Files
Share
How to cite
Statistics